Nine-Year Follow-Up of Interleukin 6 in Chronic Obstructive Pulmonary Disease – Complementary Results from Previous Studies
Robson Prudente,1 Renata Ferrari,2 Carolina Mesquita,2 Luiz Machado,2 Estefânia Franco,1 Irma Godoy,2 Suzana Tanni2 1Clinical Hospital of Botucatu Medical School, Department of Internal Medicine, Pneumology Area, Botucatu School of Medicine, São Paulo State University (UNESP), Botucatu, São Paulo, B...
Guardado en:
Autores principales: | Prudente R, Ferrari R, Mesquita C, Machado L, Franco E, Godoy I, Tanni S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0011968a77a43b0a92278e6e8d835d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer
por: Liao KM, et al.
Publicado: (2021) -
The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea
por: Lu Yan, et al.
Publicado: (2021) -
Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study
por: Chun-Mei Feng, et al.
Publicado: (2021) -
Right Atrium Volume Index in Non-Severe Chronic Obstructive Pulmonary Disease
por: Cherneva Zh., et al.
Publicado: (2020) -
Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study
por: Choi JH, et al.
Publicado: (2021)